v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
Total revenue, net $ 20,272,000 $ 2,214,000
Operating expenses    
Cost of product revenue 1,158,000 515,000
Research and development 3,928,000 3,730,000
Sales and marketing 896,000 2,493,000
General and administrative 4,108,000 4,897,000
Total operating expenses 10,090,000 11,635,000
Income (loss) from operations 10,182,000 (9,421,000)
Interest income (expense) (699,000) 56,000
Loss on extinguishment of debt (628,000) 0
Changes in fair value of freestanding and hybrid financial instruments designated at Fair Value Option (337,000) (1,343,000)
Other income (expense) 205,000 112,000
Income (loss) before income tax expense 8,723,000 (10,596,000)
Income tax expense 0 0
Net income (loss) 8,723,000 (10,596,000)
Net loss attributable to noncontrolling interest (126,000) (132,000)
Stock dividends to preferred stockholders 9,470,000  
Deemed dividend to preferred stockholders 6,063,000 0
Preferred returns to preferred stockholders 331,000 0
Net loss attributable to common stockholders $ (7,015,000) $ (10,464,000)
Net loss per share, basic $ (13.6) $ (584.45)
Net loss per share, diluted $ (13.6) $ (584.45)
Weighted-average common stock outstanding, basic 515,788 17,904
Weighted-average common stock outstanding, diluted 515,788 17,904
License revenue    
Revenue    
Total revenue, net $ 19,043,000 $ 43,000
Product revenue, net    
Revenue    
Total revenue, net 1,204,000 $ 2,171,000
Grant revenue    
Revenue    
Total revenue, net $ 25,000